4.7 Editorial Material

Human Pluripotent Stem Cell-Derived Engineered Tissues: Clinical Considerations

Journal

CELL STEM CELL
Volume 22, Issue 3, Pages 294-297

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2018.01.015

Keywords

-

Funding

  1. NIH grants [R01 HL128362, U54 DK107979, DP2 HL137188]
  2. Fondation Leducq Transatlantic Network of Excellence
  3. Robert B. McMillen Foundation

Ask authors/readers for more resources

The combined power of human pluripotent stem cells and tissue engineering promises to revolutionize medicine by building tissue patches and artificial replacement organs for patients battling diverse diseases. Here, we articulate some big questions that need to be addressed before such engineered tissues become mainstream in the clinic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available